Lasmiditan Succinate CAS 439239-92-6

Product Description:

Product Name: Lasmiditan Succinate CAS 439239-92-6

Synonyms:

2,4,6-trifluoro-N-{6-[(1-methylpiperidine-4-yl)carbonyl]pyridin-2-yl}benzamide hemisuccinate;

Chemical & Physical Properties

Appearance: Off-white powder

Assay: NLT99%

Water solubility: Water: 14 mg/mL (16.04 mM)

Solubility: DMSO: 100 mg/mL (114.57 mM);Ethanol: 9 mg/mL (10.31 mM)

Application:2,4,6-trifluoro-N-{6-[(1-methylpiperidine-4-yl)carbonyl]pyridin-2-yl}benzamide is a novel 5-HT(1F) receptor agonist acting on the central nervous system with a Ki value of 2.21 nM and no vasoconstrictive activity.

Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study. Lasmiditan showed efficacy in its primary endpoint, with a 2-hour placebo-subtracted headache response of 28.8%, though with frequent reports of dizziness, paresthesias, and vertigo.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.